PASSAGE BIO INC. - CO
1.1300
29-نوفمبر-24 13:45:00
15 متأخرة بدقائق
الأسهم
+0.4634
+69.52%
نطاق اليوم
0.7700 - 1.3300
ISIN
N/A
المصدر
NASDAQ
-
Passage Bio to Participate in Upcoming April Investor Conferences
25 مارس 2021 07:00:00 بحسب Nasdaq GlobeNewswire
-
Passage Bio Appoints Eliseo O. Salinas, M.D., MSc, as Chief Research & Development Officer
22 مارس 2021 07:00:00 بحسب Nasdaq GlobeNewswire
-
08 مارس 2021 07:00:00 بحسب Nasdaq GlobeNewswire
-
03 مارس 2021 07:00:01 بحسب Nasdaq GlobeNewswire
-
Passage Bio to Participate in Upcoming March Investor Conferences
02 مارس 2021 16:01:00 بحسب Nasdaq GlobeNewswire
-
Passage Bio to Report Fourth Quarter and Full-Year 2020 Financial Results on March 3, 2021
24 فبراير 2021 07:00:01 بحسب Nasdaq GlobeNewswire
-
Passage Bio Appoints Maxine Gowen, Ph.D. to Board of Directors
19 فبراير 2021 07:00:00 بحسب Nasdaq GlobeNewswire
-
28 يناير 2021 07:00:01 بحسب Nasdaq GlobeNewswire
-
Passage Bio Announces Pricing of Public Offering
21 يناير 2021 19:48:12 بحسب Nasdaq GlobeNewswire
-
Passage Bio Announces Launch of Proposed Public Offering
19 يناير 2021 16:05:50 بحسب Nasdaq GlobeNewswire
-
Passage Bio to Host First of a Series of 2021 Virtual R&D Events on January 25
19 يناير 2021 07:00:00 بحسب Nasdaq GlobeNewswire
-
Passage Bio Announces Plan to Deliver on Multiple Meaningful Catalysts in 2021
11 يناير 2021 07:00:01 بحسب Nasdaq GlobeNewswire
-
Passage Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference
04 يناير 2021 16:01:00 بحسب Nasdaq GlobeNewswire
-
04 يناير 2021 07:00:00 بحسب Nasdaq GlobeNewswire